Nutrients,
Journal Year:
2022,
Volume and Issue:
14(22), P. 4932 - 4932
Published: Nov. 21, 2022
The
ketone
bodies
(KBs)
β-hydroxybutyrate
and
acetoacetate
are
important
alternative
energy
sources
for
glucose
during
nutrient
deprivation.
KBs
synthesized
by
hepatic
ketogenesis
catabolized
to
acetyl-CoA
through
ketolysis
in
extrahepatic
tissues,
followed
the
tricarboxylic
acid
cycle
electron
transport
chain
ATP
production.
Ketogenesis
regulated
key
rate-limiting
enzymes,
3-hydroxy-3-methylglutaryl-CoA
synthase
2
succinyl-CoA:3-oxoacid-CoA
transferase,
respectively.
participate
various
cellular
processes
as
signaling
molecules.
bind
G
protein-coupled
receptors.
most
abundant
KB,
β-hydroxybutyrate,
regulates
gene
expression
other
functions
inducing
post-translational
modifications.
protect
tissues
regulating
inflammation
oxidative
stress.
Recently,
interest
has
been
increasing
due
their
potential
treatment
of
diseases
such
neurological
cardiovascular
cancer.
Cancer
cells
reprogram
metabolism
maintain
rapid
cell
growth
proliferation.
Dysregulation
KB
also
plays
a
role
tumorigenesis
types
Targeting
metabolic
changes
dietary
interventions,
including
fasting
ketogenic
diets,
shown
beneficial
effects
cancer
therapy.
Here,
we
review
current
knowledge
molecular
mechanisms
involved
regulation
functions,
therapeutic
diets
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(6), P. 1774 - 1808
Published: Jan. 1, 2023
Metabolic
reprogramming
is
one
of
the
most
important
hallmarks
malignant
tumors.Specifically,
lipid
metabolic
has
marked
impacts
on
cancer
progression
and
therapeutic
response
by
remodeling
tumor
microenvironment
(TME).In
past
few
decades,
immunotherapy
revolutionized
treatment
landscape
for
advanced
cancers.Lipid
plays
pivotal
role
in
regulating
immune
to
immunotherapy.Here,
we
systematically
reviewed
characteristics,
mechanism,
cells
TME,
appraised
effects
various
cell
death
modes
(specifically
ferroptosis)
metabolism,
summarized
antitumor
therapies
targeting
metabolism.Overall,
profound
microenvironment;
therefore,
may
lead
development
innovative
clinical
applications
including
sensitizing
immunotherapy.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: March 11, 2024
Abstract
Diet,
serving
as
a
vital
source
of
nutrients,
exerts
profound
influence
on
human
health
and
disease
progression.
Recently,
dietary
interventions
have
emerged
promising
adjunctive
treatment
strategies
not
only
for
cancer
but
also
neurodegenerative
diseases,
autoimmune
cardiovascular
metabolic
disorders.
These
demonstrated
substantial
potential
in
modulating
metabolism,
trajectory,
therapeutic
responses.
Metabolic
reprogramming
is
hallmark
malignant
progression,
deeper
understanding
this
phenomenon
tumors
its
effects
immune
regulation
significant
challenge
that
impedes
eradication.
Dietary
intake,
key
environmental
factor,
can
tumor
metabolism.
Emerging
evidence
indicates
might
affect
the
nutrient
availability
tumors,
thereby
increasing
efficacy
treatments.
However,
intricate
interplay
between
pathogenesis
other
diseases
complex.
Despite
encouraging
results,
mechanisms
underlying
diet-based
remain
largely
unexplored,
often
resulting
underutilization
management.
In
review,
we
aim
to
illuminate
various
interventions,
including
calorie
restriction,
fasting-mimicking
diet,
ketogenic
protein
restriction
high-salt
high-fat
high-fiber
aforementioned
diseases.
We
explore
multifaceted
impacts
these
encompassing
their
immunomodulatory
effects,
biological
impacts,
molecular
mechanisms.
This
review
offers
valuable
insights
into
application
therapies
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: June 18, 2024
Abstract
Tumorigenesis
is
a
multistep
process,
with
oncogenic
mutations
in
normal
cell
conferring
clonal
advantage
as
the
initial
event.
However,
despite
pervasive
somatic
and
expansion
tissues,
their
transformation
into
cancer
remains
rare
event,
indicating
presence
of
additional
driver
events
for
progression
to
an
irreversible,
highly
heterogeneous,
invasive
lesion.
Recently,
researchers
are
emphasizing
mechanisms
environmental
tumor
risk
factors
epigenetic
alterations
that
profoundly
influencing
early
malignant
evolution,
independently
inducing
mutations.
Additionally,
evolution
tumorigenesis
reflects
multifaceted
interplay
between
cell-intrinsic
identities
various
cell-extrinsic
exert
selective
pressures
either
restrain
uncontrolled
proliferation
or
allow
specific
clones
progress
tumors.
by
which
induce
both
intrinsic
cellular
competency
remodel
stress
facilitate
not
fully
understood.
In
this
review,
we
summarize
genetic,
epigenetic,
external
events,
effects
on
co-evolution
transformed
cells
ecosystem
during
initiation
evolution.
A
deeper
understanding
earliest
molecular
holds
promise
translational
applications,
predicting
individuals
at
high-risk
developing
strategies
intercept
transformation.
Nature,
Journal Year:
2024,
Volume and Issue:
629(8011), P. 450 - 457
Published: April 24, 2024
Three-dimensional
organoid
culture
technologies
have
revolutionized
cancer
research
by
allowing
for
more
realistic
and
scalable
reproductions
of
both
tumour
microenvironmental
structures
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Feb. 6, 2024
The
gut
microbiota
and
Short-chain
fatty
acids
(SCFAs)
can
influence
the
progression
of
diseases,
yet
role
these
factors
on
gastric
cancer
(GC)
remains
uncertain.
In
this
work,
analysis
composition
SCFA
content
in
blood
feces
both
healthy
individuals
GC
patients
indicated
that
significant
reductions
abundance
intestinal
bacteria
involved
production
were
observed
compared
with
controls.
ABX
mice
transplanted
fecal
from
developed
more
tumors
during
induction
had
lower
levels
butyric
acid.
Supplementation
butyrate
along
H.
pylori
N-methyl-N-nitrosourea
(MNU)
WT
GPR109A−/−mice
resulted
fewer
IFN-γ+
CD8+
T
cells,
but
effect
was
significantly
weakened
after
knockout
GPR109A.
Furthermore,
vitro
cells
co-cultured
or
CAR-Claudin
18.2+
as
well
vivo
tumor-bearing
studies,
have
enhanced
killing
function
against
through
G
protein-coupled
receptor
109A
(GPR109A)
homologous
domain
protein
box
(HOPX).
Together,
data
highlighted
restoration
microbial
cell
cytotoxicity
via
GPR109A/HOPX,
thus
inhibiting
carcinogenesis,
which
suggests
a
novel
theoretical
foundation
for
management
GC.
Trends in Pharmacological Sciences,
Journal Year:
2024,
Volume and Issue:
45(6), P. 537 - 551
Published: May 17, 2024
Cancer
cells
perturb
lipid
metabolic
pathways
for
a
variety
of
pro-tumorigenic
functions,
and
deregulated
cellular
metabolism
is
hallmark
cancer
cells.
Although
alterations
in
have
been
appreciated
over
20
years,
there
are
no
FDA-approved
treatments
that
target
lipid-related
pathways.
Recent
advances
pertaining
to
cell
fatty
acid
synthesis
(FAS),
desaturation,
uptake,
microenvironmental
dietary
lipids,
tumor-infiltrating
immune
illuminated
promising
clinical
applications
targeting
metabolism.
This
review
highlights
emerging
targets
tumor
may
soon
impact
treatment.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Oct. 11, 2024
The
cascade
of
metastasis
in
tumor
cells,
exhibiting
organ-specific
tendencies,
may
occur
at
numerous
phases
the
disease
and
progress
under
intense
evolutionary
pressures.
Organ-specific
relies
on
formation
pre-metastatic
niche
(PMN),
with
diverse
cell
types
complex
interactions
contributing
to
this
concept,
adding
a
new
dimension
traditional
cascade.
Prior
metastatic
dissemination,
as
orchestrators
PMN
formation,
primary
tumor-derived
extracellular
vesicles
prepare
fertile
microenvironment
for
settlement
colonization
circulating
cells
distant
secondary
sites,
significantly
impacting
cancer
progression
outcomes.
Obviously,
solely
intervening
sites
passively
after
macrometastasis
is
often
insufficient.
Early
prediction
holistic,
macro-level
control
represent
future
directions
therapy.
This
review
emphasizes
dynamic
intricate
systematic
alterations
that
progresses,
illustrates
immunological
landscape
creation,
deepens
understanding
treatment
modalities
pertinent
metastasis,
thereby
identifying
some
prognostic
predictive
biomarkers
favorable
early
predict
occurrence
design
appropriate
combinations.
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(4)
Published: April 9, 2024
Abstract
Immunotherapy
is
emerging
as
a
promising
avenue
in
oncology,
gaining
increasing
importance
and
offering
substantial
advantages
when
compared
to
chemotherapy
or
radiotherapy.
However,
the
context
of
immunotherapy,
there
potential
for
immune
system
either
support
hinder
administered
treatment.
This
review
encompasses
recent
pivotal
studies
that
assess
influence
dietary
elements,
including
vitamins,
fatty
acids,
nutrients,
small
molecules,
patterns,
caloric
restriction,
on
ability
modulate
responses.
Furthermore,
article
underscores
how
these
factors
have
modify
enhance
effectiveness
anticancer
immunotherapy.
It
emphasizes
necessity
additional
research
comprehend
underlying
mechanisms
optimizing
efficacy
therapy
defining
strategies
may
reduce
cancer-related
morbidity
mortality.
Persistent
investigation
this
field
holds
significant
promise
improving
cancer
treatment
outcomes
maximizing
benefits
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Sept. 16, 2024
Abstract
Histone
post-translational
modifications
(HPTMs),
as
one
of
the
core
mechanisms
epigenetic
regulation,
are
garnering
increasing
attention
due
to
their
close
association
with
onset
and
progression
diseases
potential
targeted
therapeutic
agents.
Advances
in
high-throughput
molecular
tools
abundance
bioinformatics
data
have
led
discovery
novel
HPTMs
which
similarly
affect
gene
expression,
metabolism,
chromatin
structure.
Furthermore,
a
growing
body
research
has
demonstrated
that
histone
also
play
crucial
roles
development
various
diseases,
including
cancers,
cardiovascular
infectious
psychiatric
disorders,
reproductive
system
diseases.
This
review
defines
nine
modifications:
lactylation,
citrullination,
crotonylation,
succinylation,
SUMOylation,
propionylation,
butyrylation,
2-hydroxyisobutyrylation,
2-hydroxybutyrylation.
It
comprehensively
introduces
modification
processes
these
HPTMs,
transcription,
replication,
DNA
repair
recombination,
structure,
well
involvement
promoting
occurrence
clinical
applications
targets
biomarkers.
Moreover,
this
provides
detailed
overview
HPTM
inhibitors
targeting
emerging
strategies
treatment
multiple
while
offering
insights
into
future
prospects
challenges.
Additionally,
we
briefly
introduce
techniques
field
research.